Relationship between behçet’s disease and oxidant and antioxidant markers

Behçet’s disease is known as a chronic and inflammatory vasculitis with multiple system and organ involvement. In this study, we aimed to evaluate the relationship between BD and oxidative stress by evaluating the total antioxidant status (TAS), total oxidant status (TOS) and oxidative stress index (OSI) in healthy control group and patients with Behçet’s disease (BD). Materials and Methods: Study groups were composed of BD patients (n = 57) and healthy controls (n = 54). Serum total TAS, TOS, (OSI) and serum lipid levels were measured by photometric method. All measurements were made on Beckman Coulter AU5800 Series (Japan). OSI was determined by the TOS / TAS ratio. Serum TAS levels in BD were lower than the healthy controls (p = 0.039). Serum levels of TOS, OSI and lipids did not differ significantly in BD patients compared to healthy controls. Also, the sensitivity of TAS for BD was high (0.825). Low TAS levels can play an important role in the etiopathology of BD. Increasing serum TAS levels may be beneficial for the clinical process. More studies are needed in this regard.

PDF

___

1. Isik A, Koca SS, Ustundag B, et al. Decreased total antioxidant response and increased oxidative stress in Behcet’s disease. Tohoku J Exp Med. 2007;212:133- 41.

2. Lee YB, Lee JH, Lee SY, et al. Association between smoking and Behçet’s disease: a nationwide population-based study in Korea. J Eur Acad Dermatol Venereol. 2019;33:2114-22.

3. Becatti M, Emmi G, Bettiol A, et al. Behçet’s syndrome as a tool to dissect the mechanisms of thrombo-inflammation: clinical and pathogenetic aspects. Clin Exp Immunol. 2019;195:322-33.

4. Hahn BH, Grossman J, Ansell BJ, et al. Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Res Ther. 2008;10:213.

5. Sezer ED, Aksu K, Caglayan O, et al. DNA damage and its relationship with other oxidative stress parameters in Behcet’s disease. Rheumatol Int. 2012;32:217-22.

6. Akar A, Arca E, Serdar MA, et al. Correlation between erythrocyte antioxidant activity, lipid peroxidation, and disease activity in patients with Behçet’s disease. J Eur Acad Dermatol Venereol. 2003;17:482-3.

7. Mittal M, Siddiqui MR, Tran K, et al. Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal. 2014;20:1126-67.

8. Barygina VV, Becatti M, Soldi G, et al. Altered redox status in the blood of psoriatic patients: involvement of NADPH oxidase and role of anti-TNF-α therapy. Redox Rep. 2013;18:100-6.

9. Karademirci M, Kutlu R, Kilinc I. Relationship between smoking and total antioxidant status, total oxidant status, oxidative stress index, vit C, vit E. Clin Respir J. 2018;12:2006-12.

10. Yilmaz S, Simsek I, Cinar M, et al. Patient-driven assessment of disease activity in Behçet’s syndrome: cross-cultural adaptation, reliability and validity of the Turkish version of the Behçet’s Syndrome Activity Score. Clin Exp Rheumatol. 2013;31:77-83.

11. Acikgoz N, Ermiş N, Yağmur J, et al. Elevated oxidative stress markers and its relationship with endothelial dysfunction in Behçet disease. Angiology. 2011;62:296-300.

12. Emmi G, Mannucci A, Argento FR, et al. Stem-Cell-Derived Circulating Progenitors Dysfunction in Behçet’s Syndrome Patients Correlates With Oxidative Stress. Front Immunol. 2019;10:2877.

13. Butta NV, Fernández-Bello I, López-Longo FJ, et al. Endothelial Dysfunction and Altered Coagulation As Mediators of Thromboembolism in Behçet Disease. Semin Thromb Hemost. 2015;41:621-8.

14. Sepici-Dinçel A, Ozkan Y, Yardim-Akaydin S, et al. The association between total antioxidant status and oxidative stress in Behçet’s disease. Rheumatol Int. 2006;26:1005-9.

15. Bozkurt M, Yüksel H, Em S, et al. Serum prolidase enzyme activity and oxidative status in patients with Behçet’s disease. Redox Rep. 2014;19:59-64.

16. Türsen U. Pathophysiology of the Behçet’s Disease. Patholog Res Int. 2012;2012:493015.

17. Akcay YD, Sagin FG, Aksu K, et al. A panel of oxidative stress assays does not provide supplementary diagnostic information in Behcet’s disease patients. J Inflamm (Lond). 2012;9:13.

18. Avci E, Akarslan ZZ, Erten H, et al. Oxidative stress and cellular immunity in patients with recurrent aphthous ulcers. Braz J Med Biol Res. 2014;47:355-60.

19. Cimen F, Yildirmak ST, Ergen A, et al. Serum Lipid, Lipoprotein and Oxidatively Modified Low Density Lipoprotein Levels in Active or Inactive Patients with Behçet’s Disease. Indian J Dermatol. 2012;57:97-101.

20. Agirgol S, Cakir E, Gumus A, et al. Evaluation of the relationship between Behcet’s disease and cardiovascular disorders through metabolic function and copeptin. Postepy Dermatol Alergol. 2019;36:609-15.

21. Şahin E, Karaman G, Uslu M, et al. Adiponectin levels, insulin resistance and their relationship with serum levels of inflammatory cytokines in patients with Behçet’s disease. J Eur Acad Dermatol Venereol. 2012;26:1498-502.